Tenet leads Health System CIO vacancies to watch. Several large U.S. health systems are searching for new technology chiefs, and one of the most prominent openings now has a date attached. Tenet Healthcare Executive Vice President and Chief Information Officer Paola Arbour will retire effective Dec. 31, 2026, according to the company's April 9 securities filing, making Dallas-based Tenet one of the biggest health system CIO vacancies to watch heading into 2027. The turnover matters because CIOs and chief digital officers now oversee some of the largest and riskiest investments health systems make, including EHR consolidations, AI deployment, cloud migration and cybersecurity. Leadership gaps can slow those projects at a time when many systems are under financial pressure to show returns on technology spending. [TABLE OF CONTENTS] Tenet sets a date for its CIO transition. Arbour will step down from her executive role at year-end but remain with Tenet part-time in a nonexecutive role through April 1, 2028, to provide transition support, according to the filing. The filing did not name a successor. Under her retirement transition agreement, Arbour remains eligible for a 2026 annual bonus but not a 2027 bonus, and her outstanding equity awards continue to vest on their existing terms, Tenet disclosed. The long transition window gives Tenet time to recruit a replacement, but the company has not publicly announced a search timeline. Where Health System CIO vacancies came from. Many of the current openings were created when executives moved to other health systems, often to larger or more prominent roles. Recent moves documented in organizations' own announcements include: * Children's Hospital of Philadelphia: Shakeeb Akhter, senior vice president and chief digital and information officer, joined Memorial Sloan Kettering Cancer Center as chief digital officer, MSK announced May 20. * Ardent Health: Anika Gardenhire, RN, chief digital and transformation officer at the Brentwood, Tenn.-based system, became Michigan Medicine's first chief digital and information officer, starting March 1, according to Michigan Medicine. * Presbyterian Healthcare Services: CIO Keith Rivera became vice president and CIO of Nebraska Medicine on June 22, according to the University of Nebraska Medical Center. * Wellstar Health System: Senior Vice President and CIO Bill Bellando was named executive vice president and CIO of Geisinger in June, he announced. Each move filled a role at the receiving system while opening one at the system left behind. At CHOP, Chief Technology Officer Wes Barnes was named interim chief digital and information officer, according to published reports. Other systems reported to have open or interim technology leadership include SSM Health, Temple Health, University of Vermont Health, UK HealthCare, UC Davis Health, Methodist Le Bonheur Healthcare and the University of Maryland Medical System, according to published reports. Several have relied on interim leaders for extended periods. A changing job description. The new titles in these moves reflect how the role is evolving. Michigan Medicine created its first chief digital and information officer position, combining IT strategy and operations with digital strategy, and said Gardenhire would oversee its multiyear IT plan and develop strategies using current and emerging technologies. MSK said Akhter would oversee the design and execution of its digital strategy across clinical, research and administrative areas. "Shakeeb brings extraordinary vision, expertise and energy to this role," said Selwyn M. Vickers, MD, MSK's president and CEO. Nebraska Medicine said Rivera's priorities include upgrading core infrastructure, improving enterprise platforms, cloud migration, cybersecurity and application modernization. Those priorities, more than traditional systems management, increasingly define what boards expect from technology leaders. Why the openings matter. The demand for experienced technology executives is high, and the candidate pool is relatively small. When a system hires a sitting CIO from a peer, it often triggers a chain of searches, as the CHOP, Ardent, Presbyterian and Wellstar vacancies illustrate. Extended interim periods can also affect major initiatives. Systems in the middle of EHR transitions, AI governance programs or cybersecurity upgrades may delay decisions until a permanent leader is in place, and vendors may find longer sales cycles at organizations without a confirmed CIO. What comes next. The Tenet opening is likely to draw the most attention because of the company's size and the defined retirement date. For other systems, the key questions are whether they keep combined digital and information officer titles, promote interim leaders or recruit externally. Executive search activity for health system CIO vacancies is likely to stay busy into 2027 as these searches conclude and new moves create additional openings.

RBC Capital reaffirms their Buy rating on Tenet Healthcare (THC). Oct. 8, 2026, 09:47 PM RBC Capital analyst Ben Hendrix maintained a Buy rating on Tenet Healthcare on October 7 and set a price target of $283.00. The company's shares closed yesterday at $259.83. Hendrix covers the Healthcare sector, focusing on stocks such as HCA Healthcare, Cigna, and Universal Health. According to TipRanks, Hendrix has an average return of 6.2% and a 51.71% success rate on recommended stocks. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Tenet Healthcare with a $283.41 average price target, representing a 9.08% upside. In a report released on September 28, Raymond James also reiterated a Buy rating on the stock with a $285.00 price target. Based on Tenet Healthcare's latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $5.63 billion and a net profit of $826 million. In comparison, last year the company earned a revenue of $5.27 billion and had a net profit of $288 million Based on the recent corporate insider activity of 55 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of THC in relation to earlier this year. Last month, Robert Kerrey, a Director at THC sold 12,010.00 shares for a total of $3,167,330.06. Read More on THC:

Is Tenet Healthcare Corporation (THC) A solid play on expanding ambulatory business? Published September 26, 2026 at 4:19 pm EDT Tenet Healthcare Corporation (NYSE:THC) is increasingly relying on its ambulatory business as an important driver of growth, combining favorable long-term outpatient trends with attractive margins. According to BMO Capital Markets, Tenet's ambulatory operations give the company exposure to an end market with favorable long-term growth characteristics. The firm expects continued investment in Tenet's hospital operations to support organic growth and help offset broader macroeconomic pressures. BMO initiated coverage of Tenet on September 22 with a Market Perform rating and a $265 price target. United Surgical Partners International (USPI), Tenet's ambulatory platform, had interests in 538 ambulatory surgery centers as of June 30. The business also operated 26 surgical hospitals across 37 states. In the second quarter, ambulatory revenue increased 9.3% year over year to $1.39 billion, highlighting the segment's continued contribution to Tenet's overall growth. The segment's profitability is also an important part of the investment thesis. Ambulatory EBITDA increased 8.8% in the second quarter, while adjusted EBITDA margin reached 39%. These results demonstrate the attractive economics of outpatient care and underscore how USPI is becoming an increasingly important component of Tenet's business mix. Risks to Tenet's ambulatory growth. Despite the growth opportunity, Tenet Healthcare Corporation's ambulatory business faces several risks that could affect the company's long-term financial performance and valuation. Tenet remains dependent on commercial insurers and government payers, making reimbursement policy an important consideration. Changes to Medicare payment rates or reimbursement policies could reduce the economic advantage associated with performing certain procedures in outpatient settings. USPI's business model also depends heavily on relationships with surgeons who bring procedures to its facilities. Competition from other ambulatory surgery center operators could make it more difficult to recruit and retain physicians. It could also increase the financial concessions required to maintain existing physician relationships. Acquisitions represent another potential risk. Tenet has expanded USPI through acquisitions and partnerships, but strong investor interest in the ambulatory surgery center market could drive acquisition multiples higher. Paying elevated valuations for new facilities could make it more difficult for Tenet to generate attractive returns on invested capital. Hedge fund positioning. Institutional investor activity provides another data point for investors watching Tenet Healthcare Corporation. According to Insider Monkey's database, the number of hedge funds holding Tenet shares increased to 61 in the second quarter from 57 in the first quarter. Several prominent funds also increased their positions. Glenview Capital increased its Tenet stake by 47% to approximately $418.25 million, while Citadel Investment Group increased its position by 322% to approximately $330.30 million. Short interest has also declined. The number of Tenet shares held short fell to 2.02 million as of September 15, from 2.52 million as of August 14. Short interest stood at approximately 2.50% of shares outstanding, indicating relatively limited short positioning around the stock. The verdict. Tenet Healthcare Corporation's expanding ambulatory platform has become an increasingly important part of its growth profile. USPI combines exposure to the continued migration of procedures toward outpatient settings with a relatively high-margin business model, while its scale offers opportunities to expand through partnerships and acquisitions. At the same time, investors need to monitor reimbursement changes, physician relationships, competitive pressures, and acquisition valuations. These factors could influence how effectively Tenet converts ambulatory growth into sustainable earnings and cash flow. The combination of ambulatory expansion, improving hedge fund participation, and declining short interest provides important context for investors assessing Tenet's growth outlook.